Shuttle Pharmaceuticals Holdings Inc Dossier - Source-backed chat

Shuttle Pharmaceuticals Holdings Inc

SHPHNASDAQ

SectorHealth Care

IndustryBiotechnology

Beta (adjusted)1.14

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $3.95Price as of 1 Oct 2026

Data confidenceNot applicable

Market Cap $18.8M

Enterprise Value $18.7M

Shares Outstanding 635.8K diluted

Next Earnings Date16 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) has undergone a fundamental business pivot, shifting from a clinical-stage oncology biotech to a Dogecoin mining-focused enterprise through its merger with United Dogecoin Inc. on May 6, 2026. While this pivot introduces a high-risk, high-reward crypto-mining narrative, the company's underlying financials remain highly distressed. Shuttle faces severe liquidity constraints, a substantial working capital deficit of $5.8 million, and a formal going-concern warning as of Q1 2026. Furthermore, the massive potential dilution from the conversion of Series B-1 preferred stock and milestone-based pre-funded warrants poses a significant headwind for common shareholders.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$0.5030%

The company fails to secure or deploy the mining rigs due to infrastructure or capital constraints. Continued cash burn exhausts the remaining $1.09 million cash balance, and the inability to raise further capital under the going-concern warning leads to insolvency or delisting from the Nasdaq Capital Market.

Base CaseCentral scenario

$3.0050%

The company successfully deploys its mining rigs but faces operational delays, high energy costs, and network difficulty increases that compress mining margins. Dilution from preferred stock conversions and warrant exercises limits upside for common stock, while the legacy biotech assets (including Molecule.ai) remain underfunded and fail to generate material value.

Bull CaseUpside scenario

$6.5020%

The rapid deployment of up to 3,000 ElphaPex Scrypt mining rigs successfully achieves a hash rate of 43,200 GH/s (representing ~1.5% of global Dogecoin capacity). A sustained bull market in Dogecoin and Litecoin significantly inflates the value of mined coins held on the balance sheet, transforming Shuttle into a highly profitable, liquid crypto-treasury play.

Scenarios reflect our research view at the research date.

Key Investment Merits

Immediate entry into the digital asset mining sector with a focus on Dogecoin and Litecoin merge-mining.
Strategic option to purchase up to 3,000 next-generation ElphaPex Scrypt mining rigs.
Ownership of the Molecule.ai platform, providing optionality in AI-driven molecular discovery if funding is secured.

Key Investment Risks

Going-concern uncertainty with a working capital deficit of approximately $5.8 million as of March 31, 2026.
Extreme potential dilution from 8,000 shares of Series B-1 Convertible Preferred Stock and up to 118,038,551 milestone-based pre-funded warrants.
High operational exposure to volatile cryptocurrency prices (DOGE and LTC) and energy costs.

Thesis Invalidation Triggers

Failure to deploy the initial fleet of mining rigs within the projected 60-day window.
Inability to obtain stockholder approval for the conversion of Series B-1 preferred stock and issuance of underlying common shares.
Delisting from the Nasdaq Capital Market due to failure to maintain minimum bid price or stockholders' equity requirements.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.